Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous anesthetic choice during electroconvulsive therapy for depression
ChiCTR2200066566Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Shanxi Medical University
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol and esketamine in major depressive disorder (MDD) (3 arms), sponsored by First Affiliated Hospital of Shanxi Medical University. Primary endpoint: Depression scale score. Started Dec 2022; status: recruiting.
02
Drugs
propofolesketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2200066566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066566.